With just 10ml of blood, this test utilizes advanced AI and Multi-omics technology to analyze ctDNA, accurately screening for 10 high-incidence cancers. Boasting 99.92% specificity, this non-invasive, radiation-free test helps you identify hidden risks early—before symptoms appear
Why Choose SPOT-MAS?
Asia’s First Clinically Validated Multi-Cancer Early Detection Blood Test:
SPOT-MAS performance is validated in a research involves 9.024 participants, showing proven accuracy in cancer signal detection and tumor location prediction.
Testing Laboratory:
The blood specimen is processed and tested at Gene Solutions Genomics Pte Ltd, a MOH-licensed clinical laboratory in Singapore. Results will be delivered to your doctor.
International Awards:
Gene Solutions’ award winning studies to screen for multi-cancer has been featured in:
WHO IS SPOT-MAS FOR?
Heavy smoking
People who have a 20 pack-year history of smoking.
Heavy drinking
People who drink 15 cans of beer a week (for men) or 08 cans of beer a week (for women)
Hereditary risks
Those who have tested positive for inherited cancer genes such as BRCA1, BRCA2, TP53
Liver diseases
People who have Hepatitis B or C.
Familial history
People whose family members had been diagnosed with cancer.